The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2019
Filed:
Jul. 31, 2017
Applicant:
Sprout Pharmaceuticals, Inc., Raleigh, NC (US);
Inventors:
Angelo Ceci, Mittelbiberach, DE;
Marcus Schindler, Hovås, SE;
Assignee:
Sprout Pharmaceuticals, Inc., Raleigh, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/135 (2006.01); A61K 31/13 (2006.01); A61K 31/34 (2006.01); A61K 45/06 (2006.01); A61K 31/131 (2006.01); A61K 31/137 (2006.01); A61K 31/335 (2006.01); A61K 31/365 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 31/13 (2013.01); A61K 31/131 (2013.01); A61K 31/137 (2013.01); A61K 31/34 (2013.01); A61K 31/365 (2013.01); A61K 45/06 (2013.01); A61K 31/135 (2013.01); A61K 31/335 (2013.01); Y10S 514/909 (2013.01);
Abstract
The invention relates to compositions for the treatment of obesity and related diseases comprising a) an active substance being not flibanserin, selected from the group consisting of active substances for the treatment of obesity and obesity related diseases and b) flibanserin, optionally in the form of pharmacologically acceptable acid addition salts thereof.